Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 4/20 | 0.59 |
| ▸ | CALCRL | Q16602 | 6/20 | 0.59 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.56 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.56 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31307292 | 0.88 | CALCRL (0.56) | EPHA2CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL5499227 | 0.88 | MAPK8 (0.58) | EPHA2CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL29868580 | 0.86 | OPRM1 (0.59) | EPHA2MAPK8MAPK9MAPK10OPRM1 | |
| SCHEMBL30974077 | 0.85 | EPHA2 (0.57) | EPHA2CALCRLKEAP1 | |
| SCHEMBL30974445 | 0.85 | CALCRL (0.55) | EPHA2CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL31281064 | 0.85 | MAPK8 (0.56) | EPHA2CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL30974054 | 0.84 | CALCRL (0.56) | EPHA2CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL30452563 | 0.84 | EPHA2 (0.57) | EPHA2CALCRLKEAP1OPRM1OPRK1 | |
| SCHEMBL30832038 | 0.84 | EPHA2 (0.62) | EPHA2CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL31743445 | 0.84 | EPHA2 (0.59) | EPHA2CALCRLMAPK8MAPK9MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2026-02-26 | — | — | US | claimed |
| CN-119317364-A | Novel isolated peptides, protein hydrolysates comprising said isolated peptides and uses thereof | 丰年(大众)有限公司 | 2025-01-14 | — | — | CN | claimed |
| WO-2023218231-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2023-11-16 | — | — | WO | claimed |
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2026-02-26 | — | — | US | disclosed |
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2026-02-26 | — | — | US | disclosed |
| JP-2025518505-A | — | ベタグロ パブリック カンパニー リミテッド | 2025-06-17 | — | — | JP | disclosed |
| CN-119317364-A | Novel isolated peptides, protein hydrolysates comprising said isolated peptides and uses thereof | 丰年(大众)有限公司 | 2025-01-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | VIP, ARGLU1, PELP1 | EPHA2 4777/4885CALCRL 557/4885MAPK8 1981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.